Avantor (AVTR) Stock Overview
Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
AVTR Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Avantor, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$8.34 |
| 52 Week High | US$13.60 |
| 52 Week Low | US$6.44 |
| Beta | 0.96 |
| 1 Month Change | 25.59% |
| 3 Month Change | 26.42% |
| 1 Year Change | -30.47% |
| 3 Year Change | -54.72% |
| 5 Year Change | -71.62% |
| Change since IPO | -48.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| AVTR | AT Life Sciences | AT Market | |
|---|---|---|---|
| 7D | 0.6% | -2.7% | 5.5% |
| 1Y | -30.5% | -11.0% | 36.3% |
Return vs Industry: AVTR underperformed the Austrian Life Sciences industry which returned -9.1% over the past year.
Return vs Market: AVTR underperformed the Austrian Market which returned 36.3% over the past year.
Price Volatility
| AVTR volatility | |
|---|---|
| AVTR Average Weekly Movement | 7.6% |
| Life Sciences Industry Average Movement | 6.6% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in AT Market | 7.3% |
| 10% least volatile stocks in AT Market | 2.6% |
Stable Share Price: AVTR's share price has been volatile over the past 3 months compared to the Austrian market.
Volatility Over Time: AVTR's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Austrian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1904 | 13,500 | Emmanuel Ligner | www.avantorsciences.com |
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies.
Avantor, Inc. Fundamentals Summary
| AVTR fundamental statistics | |
|---|---|
| Market cap | €5.63b |
| Earnings (TTM) | -€480.66m |
| Revenue (TTM) | €5.71b |
Is AVTR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AVTR income statement (TTM) | |
|---|---|
| Revenue | US$6.55b |
| Cost of Revenue | US$4.45b |
| Gross Profit | US$2.11b |
| Other Expenses | US$2.66b |
| Earnings | -US$551.40m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.81 |
| Gross Margin | 32.13% |
| Net Profit Margin | -8.42% |
| Debt/Equity Ratio | 67.8% |
How did AVTR perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/18 14:55 |
| End of Day Share Price | 2026/06/18 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Avantor, Inc. is covered by 26 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Catherine Ramsey Schulte | Baird |
| Luke Sergott | Barclays |
| Michael Ryskin | BofA Global Research |